NOP online
ISSN 1802-887X

Oncology news

Sections: Cancer research | Cancer prevention | Czech oncology | NOP On-line project

Cancer in the older population of the Czech Republic
27. 10. 2015 IBA MU | More information...

Population ageing has become a challenge to cancer care in developed countries. Particularities of the older population must be taken into account when considering cancer treatment. However, there is a lack of consensus on guidelines for this population due to the underrepresentation of older patients in clinical trials.

Balance between the centralisation and availability of cancer care: Institute of Biostatistics and Analyses develops the European model of a Comprehensive Cancer Care Network
4. 5. 2015 IBA MU | More information...

The Czech Republic has become a key player in European activities focusing on the development and assessment of cancer care; the Cancer Control Joint Action (CanCon) undoubtedly belongs to the most prestigious ones. Based on the Czech information system of cancer care, the Czech Republic has been selected as a model country for the development of a Comprehensive Cancer Care Network (CCCN). This part of the CanCon project is coordinated by Prof Lucio Luzzatto from the Tumour Institute of Tuscany (Istituto Toscano Tumori, ITT), who paid a visit to Brno on 24 April 2015 not only to learn about the Czech results up to now, but also about cancer research and healthcare provided to cancer patients in the Czech Republic in general, and in the South Moravian Region in particular.

Results of personalised invitations of Czech citizens to cancer screening programmes in 2014
16. 4. 2015 Czech Ministry of Health, Institute of Biostatistics and Analyses of Masaryk University | More information...

The project of personalised invitations of citizens to cancer screening programmes was launched in the Czech Republic in January 2014. Women are invited to participate in breast cancer screening and cervical cancer screening; men and women are invited to participate in colorectal cancer screening. The project aims to enhance the current cancer prevention programmes, and to increase their participation rates; therefore, personalised invitations are sent to citizens who do not participate in cancer screening programmes in the long term, and thus are at a higher risk of developing cancer.

Cancer screening programmes and their informational support: situation in the Czech Republic in 2014
18. 12. 2014 IBA MU | More information...

A special issue of Klinicka onkologie (the official journal of the Czech Society for Oncology), published in December 2014, is dedicated to the assessment of cancer prevention efforts and results in the Czech Republic. A team of authors not only described the current situation in cancer prevention programmes in the Czech Republic, but also pointed out weak spots in cancer prevention efforts.

Another international study confirmed longer survival of Czech cancer patients
5. 12. 2014 IBA MU | More information...

Over the last 15 years, the Czech Republic has been closing the gap on Western Europe in terms of 5-year survival rates in selected cancer types, and nowadays is significantly beyond the average of other post-communist countries. The latest results from the international study CONCORD-2 have again confirmed this trend.

Cancers in 2012 due to overweight and obesity: the Czech Republic has the highest proportion in Europe
26. 11. 2014 International Agency for Research on Cancer (IARC), Institute of Biostatistics and Analyses (IBA MU) | More information...

A new study by the International Agency for Research on Cancer (IARC), the specialised cancer agency of the World Health Organization (WHO), shows that nearly half a million new cancer cases per year can be attributed to high body mass index (BMI).

Czech Cancer Care in Numbers: a brief summary
8. 10. 2014 IBA MU | More information...

A compact description of cancer care in the Czech Republic was presented at the ESMO 2014 Congress in Madrid, Spain. The Czech Society for Oncology and the Institute of Biostatistics and Analyses of the Masaryk University worked together to highlight the alarmingly growing cancer burden of the Czech population, to explain the current National Cancer Control Programme and ongoing cancer screening programmes, and to comment the latest survival rates of Czech cancer patients.

Cancer burden in the Czech Republic: European and worldwide comparison
10. 9. 2014 IBA MU | More information...

The global cancer burden is on the rise, warned IARC at the beginning of 2014. The Czech Republic is no exception: cancer incidence rates are growing in our country, too. But where does the Czech Republic rank among other European countries (or even globally) in terms of cancer burden?

Survival rates of Czech cancer patients have improved
13. 4. 2014 IBA MU | More information...

Earlier this year, two studies analysing survival rates of cancer patients in the Czech Republic and across Europe were published [12]. Survival rates of cancer patients belong to key parameters in terms of evaluation of cancer care outcomes, and of fulfilling the National Cancer Control Programme. The good news from both studies is that outcomes of the Czech cancer care have improved in most diagnoses: both in terms of time trends, and when compared to other European countries. However, there is much space for improvements in cancer prevention efforts as well as early diagnosis of less advanced stages; and last but not least, the availability of cancer diagnosis and treatment in individual regions of the Czech Republic needs to be further improved.

Tobacco consumption in the Czech Republic ranks among the highest globally, while anti-smoking measures are among the poorest worldwide
2. 4. 2014 IBA MU | More information...

Smoking is one of the most important known risk factors for cancer. Most European countries are well aware of this fact, and have adopted various measures aimed at decreasing the number of smokers among the population, which should not only improve the population’s state of health, but also save costs for treatment of smoking-related diseases. Unfortunately, international studies and comparisons have shown that the Czech Republic is miles apart from those countries.

Personalised invitations of Czech citizens to cancer screening programmes
15. 1. 2014 IBA MU | More information...

In January 2014, a project of personalised invitations for cancer screening programmes was launched in the Czech Republic. In particular, citizens are invited to participate in colorectal cancer screening (men and women), as well as breast cancer screening and cervical cancer screening (women). Personalised invitations are aimed at citizens who have not participated in cancer screening programmes in the long term, and therefore are at a higher risk of developing cancer. The project is expected to increase participation rates in Czech cancer screening programmes.

OECD Health at a Glance 2013: Czech breast cancer screening programme led to an improvement of survival rates in breast cancer patients
28. 11. 2013 IBA MU | More information...

Health at a Glance is published by OECD every two years, providing the assessment and comparison of health care in individual member countries based on clearly defined indicators. In the area of cancer care, Health at a Glance primarily focuses on three diagnoses which can be detected at early stages, and for which organised screening programmes are widely recommended: colorectal cancer, breast cancer, and cervical cancer.

New OECD publication evaluates cancer care and survival of cancer patients
21. 11. 2013 IBA MU | More information...

On 30 October 2013, OECD published “Cancer Care” [1] as a summary of indicators for care provided to cancer patients in participating countries. According to the attached “country note” for the Czech Republic [2], cancer outcomes could be further improved, despite recent improvements in survival rates of cancer patients. Estimated 5-year survival rates for selected cancers are lower than the OECD average, and mortality rates are generally high, as a result of high cancer incidence rates among the Czech population, and a relatively late diagnosis.

» Archive